---
$id: https://graph.org.ai/products/commodity/51172321
$type: Product
source: UNSPSC
code: "51172321"
title: "Deferiprone"
class: "51172300"
classTitle: "Antidotes and emetics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Deferiprone

**UNSPSC Code**: 51172321
**Class**: [Antidotes and emetics](Antidotes and emetics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cancer tnm vessel invasion finding category with the molecular formula C7H9NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2BTY8KH53L, chemically known as 1,2-dimethyl-3-hydroxypyrid-4-one but generally known as deferiprone, which bears US NIH Compound Identifier 2972. European Medicines Agency schedules Deferiprone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06941MIG. The term DEFERIPRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). World Health Organization schedules deferiprone in its Anatomical Therapeutic Chemical (ATC) Classification. DEFERIPRONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule deferiprone under HS 29333999 and SITC 51574. As of Q4 2014, DEFERIPRONE remains the US FDA Preferred Term for this commodity. Deferiprone bears US NLM identifiers UMLS ID C0043832 and NCI Concept Code C73030. SMILES: OC1C(N(CCC1=O)C)C.

